- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
29
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | HK$68.80 | 1.3% | -20.3% | HK$195.2b | HK$109.63 | PE17.5x | E12.6% | 3.3% | Consumer Durables | ||
1119 | HK$2.24 | 1.8% | -31.3% | HK$3.8b | HK$4.84 | PS1.8x | E104.1% | n/a | Media | ||
285 | HK$28.30 | -6.6% | -4.6% | HK$63.8b | HK$43.51 | PE14.5x | E22.3% | 2.1% | Tech | ||
1382 | HK$1.62 | -4.7% | -15.2% | HK$2.3b | HK$3.32 | PE13.5x | E37.7% | 7.4% | Consumer Durables | ||
2013 | HK$1.19 | 0% | -69.7% | HK$3.6b | HK$2.32 | PS1.5x | E109.9% | n/a | Software | ||
2160 | HK$0.77 | 1.3% | -61.9% | HK$1.9b | HK$2.19 | PS5.1x | E98.6% | n/a | Healthcare | ||
1801 | HK$41.15 | 5.6% | 27.8% | HK$65.6b | HK$56.77 | PS9.9x | E50.5% | n/a | Pharmaceuticals & Biotech | ||
3998 | HK$3.90 | -1.0% | 12.7% | HK$42.6b | HK$5.58 | PE12.8x | E12.8% | 6.4% | Consumer Durables | ||
3393 | HK$6.28 | -1.7% | 115.1% | HK$6.2b | HK$6.90 | PE11x | E25.8% | 4.5% | Tech | ||
596 | HK$3.32 | 8.5% | 24.8% | HK$3.7b | HK$5.00 | PE17.3x | E38.0% | 0.9% | Software | ||
1911 | HK$7.27 | 0% | -26.2% | HK$4.1b | HK$12.69 | PS2.6x | E97.8% | 5.7% | Diversified Financials | ||
799 | HK$2.61 | -5.8% | -32.2% | HK$3.0b | HK$4.22 | PE40.5x | E51.2% | n/a | Media | ||
2325 | HK$8.30 | -4.6% | -31.4% | HK$5.0b | HK$13.99 | PS5.1x | E97.8% | 0.2% | Healthcare | ||
6616 | HK$3.90 | 2.9% | -11.8% | HK$4.8b | HK$5.83 | PE24.5x | E22.3% | 0% | Materials | ||
1548 | HK$12.96 | 6.6% | -35.4% | HK$27.8b | HK$24.14 | PS4.2x | E97.9% | 0% | Pharmaceuticals & Biotech | ||
2400 | HK$22.80 | -3.2% | 32.3% | HK$10.9b | HK$22.20 | PS2.9x | E53.7% | n/a | Media | ||
1952 | HK$19.94 | 2.8% | 7.6% | HK$6.4b | HK$26.07 | PS46.7x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
9886 | HK$1.13 | 9.7% | -58.6% | HK$1.5b | HK$1.56 | PB0.7x | E84.4% | n/a | Consumer Retailing | ||
9923 | HK$10.60 | -5.0% | -38.7% | HK$4.6b | HK$15.72 | PE359.2x | E51.5% | n/a | Diversified Financials | ||
1821 | HK$11.14 | -4.9% | -13.4% | HK$47.6b | HK$15.43 | PE29.6x | E26.3% | 2.2% | Real Estate Management and Development | ||
1516 | HK$1.69 | -1.2% | -25.9% | HK$5.2b | HK$1.87 | PB0.8x | E60.4% | 9.2% | Real Estate Management and Development | ||
3908 | HK$8.27 | -4.4% | -54.0% | HK$108.9b | HK$12.95 | PE8.2x | E20.0% | 2.4% | Diversified Financials | ||
2018 | HK$25.70 | -8.7% | 51.2% | HK$31.0b | HK$30.55 | PE38.3x | E23.7% | 0.4% | Tech | ||
2382 | HK$43.20 | -0.9% | -38.7% | HK$45.6b | HK$65.72 | PE39.3x | E24.6% | 0.5% | Tech |